Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Promotion
奔跑吧！科研－高质量抗体，让您的研究进入快车道！
奔跑吧！科研－高质量抗体，让您的研究进入快车道！
Articles
五大验证策略
GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter
GeneTex推出RAS (G12D突变体) 重组抗体 [HL10]
GeneTex的RAS（G12D突变体）重组抗体适用于IHC染色和WB。
Newsletter
「胶」你怎么做！Western blot省时小密技
Promotion
GeneTex 抗体百元试用计划 - 体验质量 试用启航
Newsletter
Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Newsletter
Dogs Provide Great Help to Human Cancer Research
Dogs Provide Great Help to Human Cancer Research
Newsletter
Improving cancer immunotherapy efficacy may depend on targeting exosomes
Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1
Literature
手册 - 抗体精选
下载 GeneTex 最新版本的抗体精选手册
Pathways
Epithelial–mesenchymal transition (EMT) Pathway
EMT is a process whereby tightly-interacting and immotile epithelial cells acquire the phenotype of loosely-adherent and motile mesenchymal cells.
Literature
单页 - RNA 结合蛋白
下载 GeneTex 最新版本的RNA结合蛋白单页
Literature
折页 - 热门产品
下载 GeneTex 最新版本的热门产品折页
Literature
单页 - 癌症免疫检查点
下载 GeneTex 最新版本的癌症免疫检查点单页
Literature
折页 - 文献支持抗体
下载 GeneTex 最新版本的文献支持抗体折页
Literature
海报 - 癌症信号
下载GeneTex最新版本的癌症信号海报
Literature
折页 - 癌症相关领域
下載GeneTex最新版本的癌症相关领域折页
![AKT antibody [N3C2], Internal](/upload/media/research/Cancer/Oncogenes/Oncoproteins_01.jpg)
![EGFR antibody [N1-2], N-term](/upload/media/research/Cancer/Oncogenes/Oncoproteins_05.jpg)
![Her2 / ErbB2 antibody [C2C3], C-term](/upload/media/research/Cancer/Oncogenes/Oncoproteins_07.jpg)
